Age(continuous, unit = 10 years) | 1.16(0.95–1.41) | 0.148 | 0.76(0.51–1.12) | 0.162 | – | – | 0.160 |
Tumor size(≥2 vs. <2 cm) | 2.44(1.45–4.13) | 0.001 | 1.72(0.55–5.38) | 0.350 | – | – | 0.340 |
Tumor type(other invasive vs. ductal invasive) | 1.20(0.63–2.29) | 0.587 | 3.33(0.64–17.23) | 0.152 | – | – | 0.196 |
Grade(G3 vs. G1-2) | 3.58(2.12–6.05) | < 0.001 | 7.10(1.23–40.86) | 0.028 | 10.34(2.33–45.97) | 0.002 | 0.014 |
Lymphovascular invasion(present vs. absent) | 1.48(0.70–3.12) | 0.305 | 1.43(0.36–5.65) | 0.608 | – | – | 0.618 |
Estrogen receptors(negative vs. positive) | 2.21(1.33–3.66) | 0.002 | 1.24(0.28–5.36) | 0.778 | – | – | 0.776 |
Progesterone receptors(negative vs. positive) | 1.74(1.06–2.86) | 0.028 | 0.81(0.17–3.77) | 0.789 | – | – | 0.788 |
HER2 status | | 0.031 | | 0.663 | | | 0.614 |
positive NT vs. negative | 2.18(1.21–3.93) | 0.009 | 1.29(0.39–4.31) | 0.683 | – | – | |
positive T vs. negative | 0.96(0.30–3.10) | 0.944 | 0.46(0.06–3.68) | 0.460 | – | – | |
uPA/PAI-1(one or both high vs. both low) | 6.46(1.47–28.43) | 0.014 | 2.79(0.57–13.67) | 0.205 | – | – | 0.166 |